Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model

Immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), have resulted in unprecedented improvements in survival for patients with lung cancer. Nonetheless, not all patients benefit equally and many issues remain unresolved, including the mechanisms of action and the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Ruiz, Asunción, Fiuza-Luces, Carmen, Martínez-Martínez, Esther, Arias, Clemente F., Gutiérrez, Lourdes, Ramírez, Manuel, Martín-Acosta, Paloma, Coronado, Maria José, Lucia, Alejandro, Provencio, Mariano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184589/
https://www.ncbi.nlm.nih.gov/pubmed/32341383
http://dx.doi.org/10.1038/s41598-020-63796-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184589/
https://www.ncbi.nlm.nih.gov/pubmed/32341383
http://dx.doi.org/10.1038/s41598-020-63796-w

Ejemplares similares